AstraZeneca COVID vaccine

2024 - 4 - 30

Shocking Revelation: AstraZeneca Admits Rare Side Effect of Covid Vaccine

AstraZeneca - Covid-19 vaccine - Covishield - Thrombosis with Thrombocytopenia Syndrome - TTS

Find out about the rare blood clotting condition linked to AstraZeneca's Covid vaccine and the ongoing legal battles in a class action lawsuit.

AstraZeneca, the pharmaceutical giant behind the Covid-19 vaccine 'Covishield,' recently made a startling admission regarding a rare side effect associated with its vaccine. In court documents submitted to the UK High Court, AstraZeneca acknowledged the existence of Thrombosis with Thrombocytopenia Syndrome (TTS) triggered by their vaccine. This rare blood clotting disorder has raised concerns globally, leading to ongoing scrutiny and legal challenges for the company.

The vaccine, developed in collaboration with Oxford University and manufactured by the Serum Institute of India, has faced backlash due to the potential risk of TTS in specific cases. Despite this acknowledgment, AstraZeneca points to global regulators who maintain that the benefits of vaccination outweigh the risks. The controversy surrounding the vaccine's safety has sparked discussions about the balance between the vaccine's effectiveness and rare side effects.

AstraZeneca's admission of the rare side effect comes amidst a class action lawsuit alleging serious harm and fatalities related to the Covid vaccine. The company's acknowledgment of the TTS risk emphasizes the need for further research and monitoring of vaccine side effects. As the legal battle continues, the global implications of the vaccine's safety remain a significant concern.

In light of the recent revelations, it is crucial for the public to stay informed about potential risks associated with vaccinations. Understanding the complexities of rare side effects like TTS can help individuals make informed decisions about their health. As the debate over vaccine safety continues, transparency and accountability from pharmaceutical companies like AstraZeneca play a vital role in maintaining public trust and confidence in vaccination programs.

Post cover
Image courtesy of "India Today"

What is TTS? The rare blood clot triggered by AstraZeneca's Covid ... (India Today)

TTB is a rare side effect acknowledged by AstraZeneca in court documents submitted to the UK High Court in a lawsuit alleging serious harm and deaths linked ...

Post cover
Image courtesy of "WION"

AstraZeneca Covid vaccine: Court case, rare side effects, admission ... (WION)

Pharmaceutical giant AstraZeneca in a damning revelation has admitted that its Covid-19 vaccine 'Covishield' can, in "very rare cases, cause TTS".

Post cover
Image courtesy of "Business Standard"

AstraZeneca's Covishield causes rare blood clot disorder TTS: What ... (Business Standard)

What is TTS: Covishield, a vaccine developed by AstraZeneca and Oxford University and manufactured by the Serum Institute of India, can, in rare instances, ...

Post cover
Image courtesy of "Moneycontrol.com"

Thrombosis with Thrombocytopenia Syndrome: What is TTS, rare ... (Moneycontrol.com)

British pharmaceutical giant AstraZeneca has acknowledged that its Covid vaccine can lead to a rare blood clotting condition known as Thrombosis with ...

Post cover
Image courtesy of "Jagran Josh"

What is AstraZeneca Vaccine? Know the Recently Discovered Side ... (Jagran Josh)

Explore details on its effectiveness, recent side effect concerns about Thrombosis with Thrombocytopenia Syndrome (TTS) and its impact on global vaccination ...

Post cover
Image courtesy of "The Hindu BusinessLine"

AZ points to global regulators saying vaccination benefits outweigh ... (The Hindu BusinessLine)

AstraZeneca-Oxford Covid-19 vaccine faces TTS risk scrutiny in UK, with global implications and ongoing legal battles.

Post cover
Image courtesy of "GB News"

AstraZeneca admits its Covid vaccine causes rare side effect (GB News)

The pharmaceutical giant is currently facing a class action lawsuit over claims it's widely distributed Covid vaccine led to deaths and serious injuries ...

Post cover
Image courtesy of "NDTV"

AstraZeneca Admits Covishield Jab Has Rare Side-Effect. Should ... (NDTV)

Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is a rare side effect of AstraZeneca's Covid vaccine, and the risks far outweigh the ...

Post cover
Image courtesy of "Livemint"

AstraZeneca admits rare blood clot risk from covid jabs as it faces ... (Livemint)

Facing a class action lawsuit in the UK, the drug company acknowledged a rare blood clotting risk from covid jabs.

Post cover
Image courtesy of "Washington Times"

AstraZeneca admits its COVID vaccine can cause deadly blood clots (Washington Times)

AstraZeneca has revealed that its COVID-19 vaccine can lead to a condition known as thrombosis with thrombocytopenia syndrome, which can be fatal.

Post cover
Image courtesy of "India Today"

AstraZeneca's Covid vaccine may cause blood clotting: Should you ... (India Today)

India Today spoke to doctors about AstraZeneca's admission and the rare side effect called TTS triggered by its Covid-19 vaccine.

Post cover
Image courtesy of "The Hindu"

AstraZeneca's submission in U.K. court nothing new, say doctors ... (The Hindu)

AstraZeneca's COVID-19 vaccine may cause rare blood clotting syndrome, but doctors in India are well aware of the risk.

Post cover
Image courtesy of "Morocco World News"

AstraZeneca Admits COVID Vaccine Can Cause Rare Blood Clots (Morocco World News)

The British pharmaceutical giant AstraZeneca has acknowledged for the first time in court documents that its COVID-19 vaccine can cause a rare side effect ...

Post cover
Image courtesy of "News@Northeastern"

AstraZeneca's COVID-19 vaccine and blood clots — what you need ... (News@Northeastern)

Pharmaceutical giant AstraZeneca admitted in court this week that its COVID-19 vaccine can cause a rare but deadly blood-clotting condition.

Post cover
Image courtesy of "The Indian Express"

AstraZeneca admits its vaccine causes clotting: Why Covishield ... (The Indian Express)

Experts explain post-vaccination risks and do the risk-benefit analysis.

Post cover
Image courtesy of "Business Standard"

AstraZeneca reaffirms Covid vaccine safety amid rare side effect ... (Business Standard)

This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare ...

Post cover
Image courtesy of "Times of India"

AstraZeneca admits its COVID vaccine, Covishield, can cause rare ... (Times of India)

AstraZeneca admits Covishield's rare side effect TTS, causing blood clots with low platelets. TTS symptoms include severe headaches, abdominal pain. T.

Post cover
Image courtesy of "NDTV"

"Sympathy Goes Out...": AstraZeneca Amid Vaccine's Side Effects ... (NDTV)

Amid concerns regarding potential side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant on Tuesday reiterated its ...

Post cover
Image courtesy of "Livemint"

'Sympathy goes out to...': AstraZeneca reaffirms safety of Covishield ... (Livemint)

AstraZeneca had acknowledged that its Covid vaccines, Covishield and Vaxzevria, 'can, in very rare cases, cause Thrombosis Thrombocytopenia Syndrome (TTS)'.

Post cover
Image courtesy of "Business Today"

'Sympathy goes out to anyone who lost loved ones,' says ... (Business Today)

The admission came a day after the pharma giant admitted in a UK court that its COVID-19 vaccine sold globally as Covishield and Vaxzevria may cause ...

Explore the last week